UK31214, a new aminoglycoside and derivative of kanamycin B.
The in vitro activity of UK31214, a kanamycin B derivative, was studied against 250 recent isolates and compared with other aminoglycosides. Against the Enterobacteriaceae (with the exception of Proteus mirabilis and Providencia stuartii) UK31214 and amikacin had similar degrees of activity (mode mi...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1980
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283780/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6775590/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.3.298 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|